Home » Topics » Regulatory » Patents

Patents
RSS

Roche patents new TLR antagonists for autoimmune disease

Feb. 8, 2022

Bristol Myers Squibb presents new FPR agonists

Feb. 7, 2022

Klotho Therapeutics synthesizes novel compounds for hypertension

Feb. 7, 2022

VelosBio identifies new anti-ROR1 ADCs

Feb. 7, 2022

Aligos Therapeutics discloses new THR agonists

Feb. 7, 2022

Tactogen patents 5-HT1B receptor agonists and MAO-A inhibitors

Feb. 7, 2022

BioWorld MedTech Patent Highlights: Week 4

From Current Patent Gazette

Feb. 4, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

New plasma kallikrein inhibitors identified at Merck Sharp & Dohme

Feb. 4, 2022

Praxis Precision Medicines discovers potassium channel subfamily T member 1 inhibitors

Feb. 4, 2022

Enanta Pharmaceuticals presents compounds for influenza, RSV infections

Feb. 4, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...